Suliman Khan graduated (PhD) from Chinese Academy of Sciences. He have served as visiting scholar Minnesota at State University, Mankato, MN, USA, Assistant professor at the University of Haripur, Pakistan, and currently working as researcher/professor at the Second Affiliated Hospital of Zhengzhou University under high young talent program. After his PhD (2019), He joined Zhengzhou University as a post-doctoral teacher and was selected as a researcher (full time young researcher). He have received several research including Scientific advancement grants in Henan province, National grant for foreign expert scientists, second level provincial award for talented researchers, and postdoctoral research grant from Chinese postdoctoral Science foundation. He study the molecular mechanism associated with neurological disorders and therapeutic efficacy of nanomedicines against cancer. He have published more than 100 papers and have been cited more than 10,000 times (H-index 37-Google Scholar). He have served as an associated editor for several journals and as reviewer for prominent journals such as Scientific data, Lancet southeast Asia, ACS Nano and so on. He have published several letters in high ranked journals including LANCET, Nature medicine, and Lancet Southeast Aisa. He was ranked in the top 2% of the Stanford University Science impact list and one of his publications remained highly cited for three consecutive years in Journal of Advanced Research. He is an active member of Society for Neuroscience, Chinese Neuroscience Society, Society of microbiology, and Thai Neuroscience society.